USA flag logo/image

An Official Website of the United States Government

THE LONG-TERM GOAL OF THIS PROJECT IS THE DEVELOPMENT OF NEWTHERAPEUTIC…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4768
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4768
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ONCOTECH, INC.
ONCOTECH, INC. 1791 KAISER AVE IRVINE, CA 92614
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: THE LONG-TERM GOAL OF THIS PROJECT IS THE DEVELOPMENT OF NEWTHERAPEUTIC STRATEGIES FOR THE CIRCUMVENTION OF DRUG RESISTANCE IN HUMAN NEOPLASMS.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE LONG-TERM GOAL OF THIS PROJECT IS THE DEVELOPMENT OF NEWTHERAPEUTIC STRATEGIES FOR THE CIRCUMVENTION OF DRUG RESISTANCE IN HUMAN NEOPLASMS. BY FIRST ESTABLISHING THE ABILITY OF THE DIFFERENTIAL STAINING CYTOTOXICITY ASSAY TO DETECT AND CIRCUMVENT DRUG RESISTANCE, THE PROJECT WILL LAY THE FOUNDATION FOR CLINICAL TRIALS DESIGNED TO APPLY INDIVIDUALIZED REGIMENS FOR THE EFFECTIVE TREATMENT OF REFRACTORY HUMAN MALIGNANCIES. THERAPIES WILL BE DESIGNED TO INCORPORATE SYNERGISTIC INTERACTIONS BETWEEN CYTOTOXIC AND NON-CYTOTOXIC AGENTS AND TO PROVIDE MAXIMAL PROTECTION TO NORMAL TISSUES. THE ULTIMATE GOAL WILL BE TO EXPAND THESE STUDIES INTO COOPERATIVE CLINICAL TRIALS AND TO REFINETHE TECHNIQUES AND EQUIPMENT USED FOR EVENTUAL DISSEMINATIONTO THE ONCOLOGIC COMMUNITY AT LARGE.

Principal Investigator:

Robert nagourney
PRINCIPAL INVESTIGATOR
2134240030

Business Contact:

Small Business Information at Submission:

Oncotech Inc
2865 Atlantic Avenue Suite 208 Long Beach, CA 90806

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No